Ticker Scorecard - AADI Basics Company: Aadi Bioscience, Inc. Common Stock IPO Date: February 12, 2018 Sector: Healthcare Industry: Biotech Market Cap: $68.9M Activated in VL: True Average Daily Range Avg Daily Range: $0.28 | 2.97% Avg Daily Range (30 D): $0.10 | 3.32% Avg Daily Range (90 D): $0.09 | 3.29% Institutional Daily Volume Avg Daily Volume: .16M Avg Daily Volume (30 D): .17M Avg Daily Volume (90 D): .25M Trade Size Avg Trade Size (Sh.): 109 Avg Trade Size (Sh.) (30 D): 207 Avg Trade Size (Sh.) (90 D): 225 Institutional Trades Total Inst.Trades: 66 Avg Inst. Trade: $1.91M Avg Inst. Trade (30 D): $.52M Avg Inst. Trade (90 D): $.52M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.8M Avg Closing Trade (30 D): $2.27M Avg Closing Trade (90 D): $2.27M Avg Closing Volume: 382.15K     News Feb 5, 2025 @ 9:05 PM Aadi Bioscience Filed Definitive Proxy Statement a... Source: Prnewswire May 6, 2024 @ 1:40 PM Is Align Technology (ALGN) Outperforming Other Med... Source: Zacks Equity Research Apr 3, 2024 @ 1:40 PM Is Aadi Bioscience (AADI) Stock Outpacing Its Medi... Source: Zacks Equity Research Mar 18, 2024 @ 1:40 PM Is Aadi Bioscience (AADI) Outperforming Other Medi... Source: Zacks Equity Research Mar 13, 2024 @ 1:05 PM Aadi Bioscience, Inc. (AADI) Reports Q4 Loss, Miss... Source: Zacks Equity Research Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.46 $-.54 $-.68 Diluted EPS $-.46 $-.54 $-.68 Revenue $ 7.21M $ 6.18M $ 5.35M Gross Profit $ 6.41M $ 5.4M $ 4.7M Net Income / Loss $ -12.55M $ -14.58M $ -18.29M Operating Income / Loss $ -13.41M $ -15.58M $ -19.51M Cost of Revenue $ .8M $ .78M $ .65M Net Cash Flow $ -10.6M $ -12.64M $ -9.11M PE Ratio     Splits Aug 27, 2021:   15:1 Dec 18, 2007:   1:4.50 Aug 31, 2005:   4:5